Kevin Weinstein

Kevin brings a deep background in successfully growing investor-backed, innovative healthcare companies. Immediately prior to joining Renalogic, he was President of population health for a technology company, Azara Healthcare. Previously he has served as CEO and in other executive positions at a variety of pioneering healthcare companies including Allscripts (NASDAQ: MDRX), ZirMed (now Waystar), and Valence Health (now part of Evolent Health (NYSE: EVH). Kevin joined Renalogic in July 2021 and serves on the company’s Board of Directors.